Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy

BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Res Ther
Autori principali: Silva dos Santos, Danúbia, Brasil, Guilherme Visconde, Ramos, Isalira Peroba Rezende, Mesquita, Fernanda Cristina Paccola, Kasai-Brunswick, Tais Hanae, Christie, Michelle Lopes Araújo, Cahli, Gustavo Monnerat, Barbosa, Raiana Andrade Quintanilha, da Cunha, Sandro Torrentes, Pereira, Jonathas Xavier, Medei, Emiliano, Campos de Carvalho, Antonio Carlos, Carvalho, Adriana Bastos, Goldenberg, Regina Coeli dos Santos
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799903/
https://ncbi.nlm.nih.gov/pubmed/29402309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0788-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi